Filing Flows › BioAge Labs (BIOA) › Q4 2025
BioAge Labs (BIOA) Q4 2025 earnings results (fourth quarter 2025)
10-K filed Mar 24, 2026
BioAge Labs (BIOA) reported revenue of $3.1M for the fourth quarter 2025 (Q4 2025) and +50% from the quarter before. Operating margin was -923.4%, net loss $25.9M (842.9% of revenue).
BioAge Labs, Q4 2025: revenue $3.1M, operating margin -923.4%, net loss $25.9M, operating cash flow −$28.3M. The chart follows the revenue to costs, profit and cash.
| Q4 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $3.1M | +50% | — |
| Operating profit | −$28.4M | — | — |
| Net earnings | −$25.9M | — | — |
| Operating cash flow | −$28.3M | — | — |
What changed
Revenue was $3.1M in Q4 2025, up 50% from the previous quarter.
Operating costs exceeded revenue by $28.4M, an operating margin of -923.4%. The quarter ended with a net loss of $25.9M, wider than the previous quarter's $20.2M loss.
Operating cash flow was −$28.3M. Non-cash charges added back $2.7M of share-based compensation. Working capital and other items used $5.0M. Capital expenditures of $112K exceeded it, leaving free cash flow of −$28.4M.
Questions
What was BioAge Labs' revenue in the fourth quarter 2025?
BioAge Labs (BIOA) reported revenue of $3.1M for the fourth quarter 2025 (Q4 2025) and +50% from the quarter before.
Was BioAge Labs profitable in the fourth quarter 2025?
Operating loss was $28.4M (-923.4% of revenue) and net loss $25.9M.
Source: BioAge Labs 10-K on SEC EDGAR.